4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-022143
Director acquired 7,605 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Molineaux Christopher P. Director | 2017-03-17 | Option exercise | +6,702 | $0.41 | $2,748 | 6,702 | D: show line 1 in the form |
| Molineaux Christopher P. Director | 2017-03-17 | Option exercise | +592 | $1.52 | $900 | 7,294 | D: show line 2 in the form |
| Molineaux Christopher P. Director | 2017-03-17 | Option exercise | +311 | $0.72 | $224 | 7,605 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Molineaux Christopher P. Director | 2017-03-17 | Option exercise · Stock option (right to buy) | −6,702 | 1,993 | D: show line 4 in the form | ||
| Molineaux Christopher P. Director | 2017-03-17 | Option exercise · Stock option (right to buy) | −592 | 462 | D: show line 5 in the form | ||
| Molineaux Christopher P. Director | 2017-03-17 | Option exercise · Stock option (right to buy) | −311 | 171 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…